Résultats de la recherche - Rebecca Dielschneider
- Résultat(s) 1 - 5 résultats de 5
-
1
-
2
-
3
Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism par Rebecca Dielschneider, Hannah Eisenstat, Si Mi, Jonathan M. Curtis, Wenyan Xiao, James B. Johnston, Spencer B. Gibson
Publié 2016Artigo -
4
Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells par Shumei Ma, Rebecca Dielschneider, Elizabeth S. Henson, Wenyan Xiao, Tricia R. Choquette, Anna R. Blankstein, Yongqiang Chen, Spencer B. Gibson
Publié 2017Artigo -
5
Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation par Shashi Gujar, Rebecca Dielschneider, Derek R. Clements, Erin Helson, Maya Shmulevitz, Paola Marcato, Da Pan, Lu-Zhe Pan, Dae‐Gyun Ahn, Abdulaziz Alawadhi, Patrick W.K. Lee
Publié 2013Artigo
Outils de recherche:
Sujets similaires
Biology
Cancer
Cancer research
Apoptosis
Biochemistry
Cancer cell
Cell biology
Genetics
Immunology
Programmed cell death
Autophagy
Chemistry
Enzyme
Immune system
Internal medicine
Lysosome
Medicine
Oncolytic virus
Reactive oxygen species
Breast cancer
CD8
Chronic lymphocytic leukemia
Context (archaeology)
Deferoxamine
FOXP3
Gemcitabine
Immunosuppression
Immunotherapy
Lapatinib
Leukemia